Is Quinapril/Hydrochlorothiazide Tablet (Quinapril And Hydrochlorothiazide) in shortage?
Yes. Quinapril/Hydrochlorothiazide Tablet is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.
Why it’s in shortage
- Discontinuation of the manufacture of the drug
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)
Maker contact: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
- Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)
Maker contact: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
- Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)
Maker contact: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)
Discontinuation of the manufacture of the drug
Maker contact: 866-850-2876
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)
Discontinuation of the manufacture of the drug
Maker contact: 866-850-2876
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)
Discontinuation of the manufacture of the drug
Maker contact: 866-850-2876
FDA recalls of the same active ingredient
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Quinapril/Hydrochlorothiazide Tablet:
- Unichem Pharmaceuticals USA Inc. recalls Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by:
- Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles,
- Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals,
- MACLEODS PHARMA USA, INC recalls Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for:
- Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured by:
- Lupin Pharmaceuticals Inc. recalls Quinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland
- Lupin Pharmaceuticals Inc. recalls Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland
- Aurobindo Pharma USA Inc. recalls Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA,
- Glenmark Pharmaceuticals Inc., USA recalls Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark
- Glenmark Pharmaceuticals Inc., USA recalls Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark
- Macleods Pharma Usa Inc recalls Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg, 30, 90 & 1000 count NDC # 33342-052-07, NDC
- Direct Rx recalls Losartan Pot/HCTZ 100/25 mg 90 Tabs NDC 72189-289-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg.
Other forms on FDA’s list
Quinapril/Hydrochlorothiazide Tablet shortage questions
Is Quinapril/Hydrochlorothiazide Tablet (Quinapril And Hydrochlorothiazide) in shortage?
Yes. Quinapril/Hydrochlorothiazide Tablet is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.
Why is there a Quinapril/Hydrochlorothiazide Tablet shortage?
FDA records the reason as: Discontinuation of the manufacture of the drug.
What should I do if I can’t get Quinapril/Hydrochlorothiazide Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.